Our carcinogenicity study protocols were approved by the Carcinogenicity Assessment Committee (CAC) of USFDA. All preclinical data at Advinus are handled through Provantis®. Digital Pathology services include efficient and validated in-house software packages for statistical analysis and interpretation of data. Advinus has the capability of submitting the data files to FDA, in format specified by the regulatory agency, for example, Standard for Exchange of Non-Clinical Data (SEND) format